Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q5370757> ?p ?o }
Showing triples 1 to 80 of
80
with 100 triples per page.
- Q5370757 subject Q7110135.
- Q5370757 subject Q8301163.
- Q5370757 subject Q8760194.
- Q5370757 abstract "Emergent BioSolutions is a multinational specialty biopharmaceutical company headquartered in Gaithersburg, Maryland. It develops vaccines and antibody therapeutics for infectious diseases, oncology and autoimmune disorders, and provides medical devices for biodefense purposes.Among the company’s notable products is BioThrax (Anthrax Vaccine Adsorbed), the only anthrax vaccine licensed by the U.S. Food and Drug Administration (FDA). The company also manufactures pharmaceuticals for adults and children with acute blood disorders, people undergoing certain liver transplants, palliative care for chemo or radiation therapy patients, hemophilia B and a varicella (Chickenpox) vaccine for high risk patients.The company has two divisions: a Biodefense division for medical countermeasures and a Biosciences division to treat infectious disease, autoimmune diseases, and cancer.Fuad El-Hibri, the founder of the company and former CEO, led the company since its founding as BioPort Inc. until his retirement on April 1, 2012. He continues to serve as the executive chairman of Emergent BioSolutions’ board of directors. The current CEO is Daniel Abdun-Nabi.".
- Q5370757 internationally "true".
- Q5370757 netIncome "53.0".
- Q5370757 operatingIncome "4.28E7".
- Q5370757 revenue "445.0".
- Q5370757 thumbnail Emergent_BioSolutions_logo.png?width=300.
- Q5370757 type Q891723.
- Q5370757 wikiPageExternalLink www.emergentbiosolutions.com.
- Q5370757 wikiPageExternalLink ucm133822.htm.
- Q5370757 wikiPageWikiLink Q101026.
- Q5370757 wikiPageWikiLink Q1037810.
- Q5370757 wikiPageWikiLink Q129104.
- Q5370757 wikiPageWikiLink Q134808.
- Q5370757 wikiPageWikiLink Q1361206.
- Q5370757 wikiPageWikiLink Q1368191.
- Q5370757 wikiPageWikiLink Q16242979.
- Q5370757 wikiPageWikiLink Q17148719.
- Q5370757 wikiPageWikiLink Q1781044.
- Q5370757 wikiPageWikiLink Q179661.
- Q5370757 wikiPageWikiLink Q1935986.
- Q5370757 wikiPageWikiLink Q204711.
- Q5370757 wikiPageWikiLink Q208413.
- Q5370757 wikiPageWikiLink Q2087302.
- Q5370757 wikiPageWikiLink Q2562598.
- Q5370757 wikiPageWikiLink Q27022.
- Q5370757 wikiPageWikiLink Q28237.
- Q5370757 wikiPageWikiLink Q3639228.
- Q5370757 wikiPageWikiLink Q44727.
- Q5370757 wikiPageWikiLink Q4773865.
- Q5370757 wikiPageWikiLink Q4917.
- Q5370757 wikiPageWikiLink Q5032343.
- Q5370757 wikiPageWikiLink Q507154.
- Q5370757 wikiPageWikiLink Q507443.
- Q5370757 wikiPageWikiLink Q5155415.
- Q5370757 wikiPageWikiLink Q5249589.
- Q5370757 wikiPageWikiLink Q5506872.
- Q5370757 wikiPageWikiLink Q574341.
- Q5370757 wikiPageWikiLink Q583725.
- Q5370757 wikiPageWikiLink Q6107396.
- Q5370757 wikiPageWikiLink Q611833.
- Q5370757 wikiPageWikiLink Q638729.
- Q5370757 wikiPageWikiLink Q6487481.
- Q5370757 wikiPageWikiLink Q6644529.
- Q5370757 wikiPageWikiLink Q679692.
- Q5370757 wikiPageWikiLink Q6837527.
- Q5370757 wikiPageWikiLink Q6853.
- Q5370757 wikiPageWikiLink Q6931269.
- Q5370757 wikiPageWikiLink Q7108.
- Q5370757 wikiPageWikiLink Q7110135.
- Q5370757 wikiPageWikiLink Q752719.
- Q5370757 wikiPageWikiLink Q7621808.
- Q5370757 wikiPageWikiLink Q7847126.
- Q5370757 wikiPageWikiLink Q7917537.
- Q5370757 wikiPageWikiLink Q79460.
- Q5370757 wikiPageWikiLink Q8084905.
- Q5370757 wikiPageWikiLink Q8301163.
- Q5370757 wikiPageWikiLink Q8760194.
- Q5370757 wikiPageWikiLink Q891723.
- Q5370757 intl "yes".
- Q5370757 name "Emergent BioSolutions".
- Q5370757 netIncome "US $53-$55 million".
- Q5370757 operatingIncome "US $42.8 million".
- Q5370757 revenue "US $445-$500 million".
- Q5370757 type Q891723.
- Q5370757 type Organization.
- Q5370757 type Agent.
- Q5370757 type Company.
- Q5370757 type Organisation.
- Q5370757 type Agent.
- Q5370757 type SocialPerson.
- Q5370757 type Thing.
- Q5370757 type Q43229.
- Q5370757 comment "Emergent BioSolutions is a multinational specialty biopharmaceutical company headquartered in Gaithersburg, Maryland. It develops vaccines and antibody therapeutics for infectious diseases, oncology and autoimmune disorders, and provides medical devices for biodefense purposes.Among the company’s notable products is BioThrax (Anthrax Vaccine Adsorbed), the only anthrax vaccine licensed by the U.S. Food and Drug Administration (FDA).".
- Q5370757 label "Emergent BioSolutions".
- Q5370757 depiction Emergent_BioSolutions_logo.png.
- Q5370757 homepage www.emergentbiosolutions.com.
- Q5370757 name "Emergent BioSolutions".